语前聋患儿6岁前与6岁后植入人工耳蜗效果的比较

目的比较6岁前与6岁后两个年龄组语前聋患儿人工耳蜗植入术后的听觉言语康复的效果. 方法对31例语前聋人工耳蜗植入患儿,术后随访0.5～4年,按手术年龄分成A组(1.0～5.9岁)和B组(6.0～17.9岁),进行术后的听觉和言语识别率的评估. 结果 31例语前聋人工耳蜗植入患儿全部手术成功,全部建立了主观听性反应.A组的纯音听力水平平均为30dBSPL,开放式言语识别率平均为90%.B组的纯音听力水平平均为36dBSPL,开放式言语识别率平均为85%. 结论植入人工耳蜗的语前聋患儿1.0～5.9岁与6.0～17.9岁比较,在术后的言语识别率和语言清晰度两方面的听觉言语康复效果有显著性差异,年龄越小效果越好.因此,为达到满意的听觉言语康复效果,人工耳蜗植入的时机最好在6岁之前.     

语前聋成年患者接受人工耳蜗植入的手术效果评估

通过客观及主观听力学评估来确定人工耳蜗植入是否对语前聋成年患者言语发育有促进作用。采用回顾分析患者术后的开放式言语识别率等客观指标及患者生活质量等主观指标。结果是 1989～ 1999年共完成 198例成年患者人工耳蜗植入手术 ,其中4 4例为语前聋 ,分别植入美国Nucleus 2 2、Nucleus2 4或Clarion人工耳蜗装置。患者平均手术年龄 34岁 (14～ 6 2岁 ) ,通过开放式言语识别率测试 (包括字词、短语和短句识别 )可以发现自幼接受不同听力训练的语前聋患者之间存在显著性差异。结论 :接受人工耳蜗植入手术的语前聋患者手术效果的确不如语后…     

大前庭水管语前聋患儿的人工耳蜗植入

目的探讨大前庭水管语前聋患儿人工耳蜗植入手术方法及可行性,并对术后听觉言语康复效果进行评估。方法回顾性分析2001年7月～2011年9月收治的27例大前庭水管语前聋患儿的临床资料,均为极重度聋或全聋,其中男19例,女8例,年龄1.6～4.0岁,平均2.5岁。均行右耳人工耳蜗植入,于术后6个月行声场测听,测试言语频率平均听阈,开机训练1年后,进行限定词表言语测听及非限定词表言语测听评估听力康复效果。结果 27例患儿中,术中发生"井喷"者4例,经术中采用小块肌肉或筋膜严密封堵电极周围空隙,有效防止了外淋巴漏。术后经开机康复训练6个月后,声场测听言语频率平均听阈为25～30dB nHL,平均27.5±4.5dBnHL;开机训练1年后,限定词表言语测听言语识别率平均为83.3%,非限定词表言语测听言语识别率平均为81.6%。结论大前庭水管语前聋患者可行人工耳蜗植入;术前完善的影像学评估、良好的手术视野以及术中严密封堵电极周围空隙是预防"井喷"及手术成功的关键;术后听觉言语康复效果满意。     

243例人工耳蜗植入围手术期处理与术后效果

目的总结243例多导人工耳蜗植入术围手术期的处理经验和听觉语言康复效果。方法介绍我们在多导人工耳蜗植入术围手术期的处理方法。术前评估：主要包括听力学评估、影像学评估和智力心理评估。手术方法介绍了不同型号人工耳蜗插入电极的要领，特别强调了24R（Contuor Advance）型植入电极时，不要主动向外拔金属丝。结果243例患者术后6个月用声场测听啭音语言频率平均听阈达到25-35dB（nHL），平均27．4±4．8dB。开机后1年的开放词表言语分辨率平均达到87．7％。其中成人语后聋患者术后Mapping后全部能听到家人叫他名字。经2个月3～5次调试，声场测听阈在28．1±5．4dB，非限定词表（Openset）言语测听，识别率达82％～93％，平均91．6％。学龄前的语前聋儿童，开机后1～2个月，声场测听都能达到30dB（nHL）或更佳。经过1年以上语训，测定63名可合作儿童的限定词表（Closeset）言语测听，言语识别率平均达N88．6％，非限定词表（Openset）言语测听，识别率平均达83．7％。7岁以上语前聋的儿童，开机后12个月测定26例合作语前聋儿童的Closeset言语识别率平均达Nsl．6％，Openset言语识别率平均达78．2％。结论人工耳蜗植入是治疗全聋患者的最佳选择。对语前聋患者而言，植入年龄最好在7岁前。人工耳蜗植入后，听觉语言康复工作将是一项长期的工作，需要家庭、社会、医生和聋康老师的共同努力。     

语后聋长期全聋耳的人工耳蜗植入

目的 探讨语后聋长期全聋耳的人工耳蜗植入术后效果.方法 双侧听力下降时间不同步、双侧耳聋程度不一致的语后聋患者4例,对重度聋时间较长(均>10年)、耳聋程度较重侧进行植入人工耳蜗,分别在开机后6个月、12个月,使用心理物理学测试(T/C值),术后声场内最佳助听条件下言语频率平均听阈(pure-tonethreshold average,PTA).安静及噪声环境巾的言语识别率(HINT句表),单音节词识别率(HOPE词表),汉语声调识别(MESP),听觉行为分级标准(CAP),成人生活质量调奁问卷等评价指标,评价其术后听觉言语康复效果.结果 4例受试者在开机半年至一年内均达到了较为理想的康复效果,PTA接近或达到正常水平;安静环境中的言语识别率平均达到90%以上,噪声环境中平均达到70%;植入者可以很好地识别汉语声调;人工耳蜗为植入者带来了较高的社会效益.患者对人工耳蜗的植入效果均表示满意.结论 4例受试者都选择重度聋时间较长侧作为人工耳蜗植入侧,开机后均在较短时间内获得了良好的听觉言语康复效果,充分发挥了人工耳蜗的功能和优势的同时.听力相对较好侧耳还町继续佩戴助听器,保留了患者双耳聆听和日后接收其它治疗的机会,最大限度地为患者创造了最佳聆听条件.     

语前聋青少年人工耳蜗满意度问卷设计和调查分析

目的：人工耳蜗植入技术(Cochlear Implant)使双侧重度及极重度感音神经性耳聋的语后聋患者和年龄较小的语前聋患者在言语识别方面改善较大，但对语前聋青少年人工耳蜗植入患者术后是否受益尚存在争议。本文研究语前聋青少年人工耳蜗的获益情况。方法：以语前聋青少年为研究对象，关注交流能力和生活质量改善等情况，设计语前聋青少年CI使用效果和满意度的调查问卷并分析患者人工耳蜗术后获益效果和满意度以及相关影响因素。结果：调查结果显示所有家长均对孩子植入人工耳蜗后的声音获得非常满意，且认为人工耳蜗对整体综合交流能力的改善有一定帮助，患者本人及家长都愿意选择CI。结论：对语前聋青少年CI植入者不应把言语测试识别率得分的提高作为评判人工耳蜗获益情况的唯一标准，还应考虑人工耳蜗在提高患者综合交流能力和生活质量方面的帮助效果。     

成人语前聋和语后聋人工耳蜗植入效果分析

目的分析成人人工耳蜗植入术后听觉及言语康复效果情况,探讨成人行人工耳蜗植入适应症的选择。方法对中国医科大学附属第一医院耳鼻咽喉科收治的18岁以上行人工耳蜗植入术患者52例进行测试,分为语前聋无干预组(9例)、语前聋佩戴助听器组(27例)、语后聋(16例)三组。采用声场助听听阈测试、电刺激听觉反应阈值(Threshold,THR)、最大舒适阈值(Maximum comfort level,MCL)评价其声音感知能力;采用普通话言语测听材料MSTMs中双音节词表评价其言语分辨能力。分别在开机6个月及24个月进行评估。结果开机6个月后三组声场助听阈值、THR、MCL均值无统计学差异。双音节识别率在开机6个月时语前聋无干预组8.78%、语前聋助听器组16.44%、语后聋组53.13%;在开机24个月时各组双音节识别率均上升,语前聋无干预组达18.22%、语前聋助听器组达52.89%、语后聋组达84.31%,语前聋助听器组提高明显。结论成人语前聋患者术后可获得与语后聋相近的听觉感知水平,长期使用人工耳蜗可加强言语识别能力,对术前有听觉言语基础的成人语前聋患者应积极行人工耳蜗植入术。     

语后聋成人人工耳蜗植入后言语感知能力的测评

目的通过对植入人工耳蜗的语后聋成人听力言语感知能力的测评,探讨人工耳蜗对语后聋成人言语康复的作用.方法受试者为14名语后聋成人患者,男性9例,女性5例;耳蜗植入年龄22岁～67岁,平均46岁;耳聋时间6年-42年,平均16年.在人工耳蜗植入6个月、12个月及24个月时,进行开放性单词和短句言语感知测试.分别在三种模式下进行:只听模式(开放人工耳蜗)、听觉加视觉模式(开放人工耳蜗加唇读)及视觉模式(关闭人工耳蜗只用唇读).结果在听觉模式及听觉加视觉模式下,患者对单词和句子的正确感知随人工耳蜗使用时间而不断改善.术后6个月,听觉模式下的开放性单词和短句的正确感知率分别是38%和54%;听觉加视觉模式下的开放性单词和短句的正确感知率分别是70%和76%.术后24个月,听觉模式下的开放性单词和短句的正确感知率分别是65%和72%;听觉加视觉模式下的开放性单词和短句的正确感知率分别是84%和88%.结论人工耳蜗植入能显著改善语后聋成人的言语感知能力,并随着人工耳蜗使用时间的增加,言语感知能力逐渐得到提高.     

先天性语前聋中国儿童双耳人工耳蜗植入疗效观察

目的：评估双侧耳人工耳蜗植入对极重度感音神经性语前聋患儿的听觉与言语康复疗效。方法：2例先天性极重度感音神经性聋儿童，单侧耳人工耳蜗植入术后2年和3年分别施行对侧耳人工耳蜗植入。术后1年评估患儿左、右耳单耳及双耳人工耳蜗助听听阈和言语识别率。以及言语清晰度。结果：①双耳人工耳蜗助听与单耳人工耳蜗助听相比。平均听阈降低分别为13dB和11dB；②在安静环境中双耳人工耳蜗植入儿童的言语识别率(开放项列)分别平均提高为9％和10％，2例双耳人工耳蜗植入儿童的言语识别率(开放项列)分别达97％和95％；③在嘈杂环境中对言语的识别能力明显提高；④言语清晰度有明显改善。结论：双耳人工耳蜗植入可明显提高极重度感音神经性语前聋患儿在安静和噪声环境下的言语识别率，对语前聋儿童的言语和语言发育有明显的帮助。     

92例人工耳蜗术后不同阶段康复评估效果分析

目的通过对92例7岁以下植入人工耳蜗的语前聋儿童进行分阶段的听觉、言语康复效果评估,探讨7岁以下儿童植入人工耳蜗后在不同阶段的听觉、语言康复效果及其影响因素。方法本研究采用评估词表及标准评估程序,对测试对象进行听觉能力及语言能力评估。结果听觉言语识别率:术后3个月平均达到46%,6个月达到71%,9个月达到84%,12个月达到89%;语言能力:术后3个月语言年龄平均达到1.3岁,6个月平均达到2.0岁,9个月平均达到2.5岁,12个月平均达到2.9岁。结论人工耳蜗能够帮助重度听力障碍者改善听力,术后经过一年系统康复训练,在听觉识别和语言能力上较术前有显著提高。     

The expression of vascular endothelial growth factor (VEGF) and VEGF‐C in early laryngeal cancer: relationship with radioresistance

The expression of vascular endothelial growth factor (VEGF) and VEGF‐C in early laryngeal cancer: relationship with radioresistance Angiogenesis is essential for tumour growth and invasion. Vascular endothelial growth factor (VEGF) is a prime mediator of tumour angiogenesis. VEGF‐C is a closely related protein that effects lymphatic endothelial cells and may be important in the process of lymphatic metastasis. The purpose of this study was to evaluate the expression of these cytokines in patients with T1 and T2a glottic, squamous cell carcinoma, in comparison with normal epithelial control tissue, to ascertain any association with radioresistance. Twenty‐two tumours treated by radiotherapy (13 radiosensitive, nine radioresistant) and seven normal control tissues were studied. The minimum follow‐up was 2 years after radiotherapy. Expression of VEGF and VEGF‐C was evaluated by immunohistochemistry of formalin‐fixed, paraffin‐embedded biopsy specimens. Analysis was carried out using a quantitative computer image analyser. Both VEGF and VEGF‐C were detectable in tumour and normal control specimens. There was increased expression in tumour specimens of both VEGF (P = 0.03) and VEGF‐C (P < 0.001). In addition, the expression of VEGF‐C was associated with tumours of higher histological grade (P = 0.021). There was, however, no difference in VEGF and VEGF‐C expression between radioresistant and radiosensitive tumours. The expression of VEGF and VEGF‐C is increased in early laryngeal squamous cell carcinoma (SCC). However, measuring the expression of these proteins cannot predict radioresistance in this tumour group.     

Treatment of Maxillary Sinus Carcinoma: Clinical Results Using the Kitasato Modality

The conventional therapeutic regimen for maxillary sinus carcinoma consists of dissection of the maxilla, full-dose irradiation and extensive chemotherapy. However, the results obtained with this treatment are often poor. Even when patients recover, their quality of life is significantly reduced as a result of deformity of facial structures and swallowing and articulation dysfunctions. A retrospective analysis of 68 patients with maxillary sinus carcinoma treated with the Kitasato modality between 1975 and 1999 was conducted. All patients underwent pergingival maxillary sinus surgery combined with pre- and postoperative irradiation therapy with standardized total doses of 16 Gy; the postoperative irradiation was given in combination with regional intra-arterial infusion chemotherapy administered via the superficial temporal artery. All visible tumor lesions were removed where possible in order to preserve or facilitate cellular immunity after surgery. The cumulative 5-year survival rates were 85.7% for Stage II patients, 88.1% for Stage III, 76.6% for Stage IVA and 75.0% for Stage IVB.     

Tongue Base Reduction with Temperature-controlled Radiofrequency Volumetric Tissue Reduction for Treatment of Obstructive Sleep Apnea Syndrome

In recent years a considerable effort has been made to establish the use of different surgical techniques for the treatment of obstructive sleep apnea syndrome (OSAS). Nevertheless, treatment of hypopharyngeal obstruction due to tongue base hypertrophy remains in many ways an unsolved problem. The aim of this study was to evaluate the safety and efficacy of tongue base reduction with temperature-controlled radiofrequency volumetric tissue reduction in the treatment of OSAS. Twenty patients with OSAS and tongue base hypertrophy were treated with radiofrequency tissue ablation. An intensified treatment protocol was used, delivering 2,800 J per treatment session under local anesthesia. Two nights of polysomnography testing were performed before and after treatment. Daytime sleepiness, snoring and postoperative morbidity were assessed using questionnaires. Mean respiratory disturbance index (RDI) was reduced from 32.1 to 24.9/h after a mean of 3.4 treatment sessions. Six patients (33%) were cured after the procedure (reduction in RDI of &#83 50% and a postoperative RDI of <15/h) and ten (55%) showed an improvement of >20% in their RDI. Daytime sleepiness and snoring improved significantly. Peri- and postoperative morbidity was low; one severe complication occurred (tongue base abscess). We were able to achieve similar cure and responder rates to those reported in a recently published pilot study but with a reduced number of treatment sessions. We believe that this technique may improve patient acceptance and have beneficial cost implications.     

Cervical Reflex Induced by Click Stimuli in Cats

We studied click-evoked potentials in the anterior horn of the spinal cord in 17 cats. A concentric needle electrode was inserted into the anterior horn of the spinal cord at levels C3-C6. Potentials evoked with 105 dB SPL clicks were recorded with a peak latency of 4.89-5.10 ms only at the C3 level. These responses were observed 45-60 dB SPL above the auditory brainstem response (ABR) threshold, and no potentials were evoked by stimulation of the contralateral ear. Average was performed 100 times with changes in stimulation frequency of 1-20 Hz. The amplitude of the potentials decreased with increasing stimulus frequency, but there were no changes in ABRs. The responses disappeared after destruction of the medial vestibulospinal tract at the obex level, but ABRs were still recorded. The spinal nucleus of the accessory nerves was located in the anterior horn of the spinal cord at levels C1-C6, and the sternocleidomastoid muscle motoneurons were found at levels C1-C3. The click-evoked potentials recorded in this study reflect responses of the spinal nucleus of accessory nerves through the vestibulospinal tract to click stimulation. The responses have the same characteristics as vestibular-evoked myogenic potentials that can be recorded using surface electrodes over the sternocleidomastoid muscles of humans.     

Lack of significant estrogen and progesterone receptor expression in nasal telangiectasias in hereditary hemorrhagic telangiectasia: an immunohistochemical analysis

Obstructive sleep apnea syndrome (OSAS) is characterized by snoring and apnea during sleep leading to decreased oxygen saturation and disturbed sleep, excessive daytime sleepiness and neuropsychological disturbances. This study investigates cognitive neuropsychological abilities in a group of 53 OSAS patients before and after treatment with uvulopalatopharyngoplasty. General intellectual ability, verbal learning and memory as well as executive functioning were measured at baseline and 6 months postoperatively. After surgery there were significant improvements in verbal learning and memory (mean change - 39, SD 57.3, p <0.001), recall (mean change - 24.3, SD 39.3, p <0.001) and executive functioning (as assessed by percentage of errors on the Wisconsin Card Sorting Test; mean change-9.1, SD 15.7, p <0.001). These improvements were in accordance with improvements in the degree of sleep apnea, the oxygen desaturation index (mean change -9.7, SD 15.9, p <0.001) and arterial minimum oxygen saturation (mean change 4.5%, SD 10.2%, p <0.01). Surgical treatment seems to improve verbal learning, memory and recall and executive functions in parallel with better oxygenation in OSAS.     

Measurement of chemosensory function

Although hundreds of thousands of patients seek medical help annually for disorders of taste and smell, relatively few medical practitioners quantitatively test their patients' chemosensory function, taking their complaints at face value. This is clearly not the approach paid to patients complaining of visual, hearing, or balance problems. Accurate chemosensory testing is essential to establish the nature, degree, and veracity of a patient's complaint, as well as to aid in counseling and in monitoring the effectiveness of treatment strategies and decisions. In many cases, patients perseverate on chemosensory loss that objective assessment demonstrates has resolved. In other cases, patients are malingering. Olfactory testing is critical for not only establishing the validity and degree of the chemosensory dysfunction, but for helping patients place their dysfunction into perspective relative to the function of their peer group. It is well established, for example, that olfactory dysfunction is the rule, rather than the exception, in members of the older population. Moreover, it is now apparent that such dysfunction can be an early sign of neurodegenerative diseases such as Alzheimer's and Parkinson's. Importantly, older anosmics are three times more likely to die over the course of an ensuring five-year period than their normosmic peers, a situation that may be averted in some cases by appropriate nutritional and safety counseling. This review provides the clinician, as well as the academic and industrial researcher, with an overview of the available means for accurately assessing smell and taste function, including up-to-date information and normative data for advances in this field.